FilingReader Intelligence
GlaxoSmithKline Pharmaceuticals to consider first quarter results
July 4, 2025 at 07:10 PM UTC•By FilingReader AI
GlaxoSmithKline Pharmaceuticals Limited announced that a meeting of its Board of Directors will take place on Friday, August 1, 2025, to review and approve the unaudited financial results for the first quarter ended June 30, 2025. The announcement, made in accordance with Listing Obligations and Disclosure Requirements Regulations, 2015, was submitted to the BSE. The company is headquartered in Mumbai.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:GLAXO•Bombay Stock Exchange
News Alerts
Get instant email alerts when GlaxoSmithkline Pharmaceuticals publishes news
Free account required • Unsubscribe anytime